Author:
Morgan Paul,Brown Dean G.,Lennard Simon,Anderton Mark J.,Barrett J. Carl,Eriksson Ulf,Fidock Mark,Hamrén Bengt,Johnson Anthony,March Ruth E.,Matcham James,Mettetal Jerome,Nicholls David J.,Platz Stefan,Rees Steve,Snowden Michael A.,Pangalos Menelas N.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference132 articles.
1. Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3, 711–716 (2004).
2. Garnier, J. Rebuilding the R&D engine in big pharma. Harvard Bus. Rev. 86, 68–76 (2008).
3. Peck, R. W., Lendrem, D. W., Grant, I., Lendrem, B. C. & Isaacs, J. D. Why is it hard to terminate failing R&D projects in pharmaceutical R&D? Nat. Rev. Drug Discov. 14, 663–664 (2015).
4. O'Hagan, P. & Farkas, C. Bringing pharma R&D back to health. Bain Brief http://www.bain.com/publications/articles/bringing-pharma-r-and-d-back-to-health.aspx (2009).
5. Scannell, J. W., Blanckley, A., Bolden, H. & Warrington, B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11, 191–200 (2012).
Cited by
317 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献